Patent classifications
A61K36/70
Chinese Herbal Oral Paste for Conditioning Dampness-heat Constitution and Processing Method therefor
The present application discloses a Chinese herbal oral paste for conditioning dampness-heat constitution. The Chinese herbal oral paste includes the following components: baical skullcap root, unprocessed rehmannia root, plantain seed, purslane herb, angelica, cardamon fruit, virgate wormwood herb, rice beans, weeping forsythia capsule, thunberg fritillary bulb, Chinese waxgourd peel, mint, dried tangerine peel, prepared atractylodes rhizome, waxgourd seed, common anemarrhena rhizome, amur cork-tree, golden buckwheat rhizome, fuling, Chinese yam, bitter apricot seed, coix seed, bamboo leaf, Chinese wolfberry root-bark, ural licorice root tip, common selfheal fruit-spike, white mulberry root-bark, ash bark, tortoise-plastron gelatin, turtle shell gelatin, and xylitol. The Chinese herbal oral paste of the present disclosure has a higher drug concentration and good taste, is particularly suitable for health preserving in winter and conditioning the dampness-heat constitution, will not create negative effects to the human body at all, and can achieve certain efficacy of strengthening physical health.
Chinese Herbal Oral Paste for Conditioning Dampness-heat Constitution and Processing Method therefor
The present application discloses a Chinese herbal oral paste for conditioning dampness-heat constitution. The Chinese herbal oral paste includes the following components: baical skullcap root, unprocessed rehmannia root, plantain seed, purslane herb, angelica, cardamon fruit, virgate wormwood herb, rice beans, weeping forsythia capsule, thunberg fritillary bulb, Chinese waxgourd peel, mint, dried tangerine peel, prepared atractylodes rhizome, waxgourd seed, common anemarrhena rhizome, amur cork-tree, golden buckwheat rhizome, fuling, Chinese yam, bitter apricot seed, coix seed, bamboo leaf, Chinese wolfberry root-bark, ural licorice root tip, common selfheal fruit-spike, white mulberry root-bark, ash bark, tortoise-plastron gelatin, turtle shell gelatin, and xylitol. The Chinese herbal oral paste of the present disclosure has a higher drug concentration and good taste, is particularly suitable for health preserving in winter and conditioning the dampness-heat constitution, will not create negative effects to the human body at all, and can achieve certain efficacy of strengthening physical health.
PHARMACEUTICAL COMPOSITION COMPRISING REFINED INDIGO NATURALIS EXTRACTS AND THE USE THEREOF
A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition.
PHARMACEUTICAL COMPOSITION COMPRISING REFINED INDIGO NATURALIS EXTRACTS AND THE USE THEREOF
A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition.
Prebiotic Acne Treatment
A topical composition comprising an effective amount of a prebiotic capable of nourishing and encouraging skin microorganisms such as S. epidermidis to colonize the skin and supplant acne-causing bacteria such as P. acnes. Additional components can be used by S. epidermidis to create short chain fatty acids that inhibit growth of P. acnes. The preferred prebiotics are Camellia Sinensis Leaf Extract, Glycyrrhiza Glabra (Licorice) Root Extract, and Chamomilla Recutita (Matricaria) Flower Extract. PEG-12 is used by S. epidermidis to create short chain fatty acids that inhibit P. acnes. The composition is highly effective in a method of treating acne.
Prebiotic Acne Treatment
A topical composition comprising an effective amount of a prebiotic capable of nourishing and encouraging skin microorganisms such as S. epidermidis to colonize the skin and supplant acne-causing bacteria such as P. acnes. Additional components can be used by S. epidermidis to create short chain fatty acids that inhibit growth of P. acnes. The preferred prebiotics are Camellia Sinensis Leaf Extract, Glycyrrhiza Glabra (Licorice) Root Extract, and Chamomilla Recutita (Matricaria) Flower Extract. PEG-12 is used by S. epidermidis to create short chain fatty acids that inhibit P. acnes. The composition is highly effective in a method of treating acne.
Methods and compositions for improving gut microbiota population
A method and a composition for improving gut micro biota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut micro biota population in a subject. The first gut micro biota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin-producing bacterium.
Methods and compositions for improving gut microbiota population
A method and a composition for improving gut micro biota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut micro biota population in a subject. The first gut micro biota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin-producing bacterium.
Methods and compositions for improving gut microbiota population
A method and a composition for improving gut micro biota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut micro biota population in a subject. The first gut micro biota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin-producing bacterium.
ORALLY ADMINISTERED COMPOSITION FOR TREATING CYSTIC FIBROSIS, COPD, ASTHMA AND OTHER INFLAMMATORY CONDITIONS
The invention relates to a new orally administered composition, which in present embodiments is a standardized phytochemical formulation but other embodiments may contain designed molecules. This formulation is capable of suppressing inflammation in a variety of disease conditions having an underlying inflammatory component, including but not limited to cystic fibrosis, COPD, asthma, and pancreatitis. It is an objective of the invention to provide a non-toxic therapy, which exhibits anti-oxidant anti-inflammatory properties without deleterious side effects.